Summary
Cencora, Inc. (COR), formerly AmerisourceBergen Corporation, reported its financial results for the quarter ended June 30, 2008. The company saw a notable increase in total revenue, driven by growth in its Pharmaceutical Distribution segment and the acquisition of Bellco Health. However, this top-line growth was accompanied by a significant decrease in net income, largely due to a substantial impairment charge related to the planned divestiture of its PMSI business. This charge, combined with other operating expenses and a shift in revenue recognition from bulk deliveries, impacted overall profitability. Despite the decline in net income, the company's core pharmaceutical distribution business demonstrated resilience with increased operating income. Cencora also continued its share repurchase program, indicating a commitment to returning value to shareholders. Investors should monitor the impact of the PMSI divestiture and ongoing industry trends, such as changes in pharmaceutical reimbursement policies and competition, on future financial performance.
Financial Highlights
29 data points| Revenue | $18.00B |
| Cost of Revenue | $17.50B |
| Gross Profit | $498.05M |
| SG&A Expenses | $271.10M |
| Operating Income | $197.53M |
| Net Income | -$108.02M |
| EPS (Basic) | $-0.34 |
| EPS (Diluted) | $-0.34 |
| Shares Outstanding (Basic) | 319.06M |
| Shares Outstanding (Diluted) | 322.23M |
Key Highlights
- 1Total revenue increased by 10% to $18.0 billion for the quarter ended June 30, 2008, compared to the prior year period, driven by the Pharmaceutical Distribution segment and the Bellco acquisition.
- 2Net loss for the quarter was $(108.0 million), a significant decline from a net income of $129.9 million in the prior year quarter, primarily due to a $222.5 million non-cash charge for the divestiture of the PMSI business.
- 3The Pharmaceutical Distribution segment's operating income increased by 22% to $205.4 million for the quarter, demonstrating strength in the core business.
- 4The company recorded a $222.5 million non-cash charge related to the planned divestiture of its PMSI business, which included a $199.1 million goodwill impairment.
- 5The company repurchased approximately $553.7 million of its common stock during the first nine months of fiscal 2008.
- 6As of June 30, 2008, the company had $144.0 million remaining under its share repurchase program.